DAVID POPLACK to Leukemia, Experimental
This is a "connection" page, showing publications DAVID POPLACK has written about Leukemia, Experimental.
Connection Strength
0.121
-
Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation. Cancer Res. 1985 Jan; 45(1):217-20.
Score: 0.061
-
Experimental approaches to the treatment of CNS leukemia. Am J Pediatr Hematol Oncol. 1979; 1(2):141-9.
Score: 0.040
-
Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline. Isr J Med Sci. 1988 Sep-Oct; 24(9-10):477-82.
Score: 0.020